1. 1473PImmune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients. (23rd October 2018) Authors: Kubo, T; Watanabe, H; Ninomiya, K; Kudo, K; Minami, D; Murakami, E; Ochi, N; Ninomiya, T; Harada, D; Yasugi, M; Ichihara, E; Ohashi, K; Fujiwara, K; Hotta, K; Tabata, M; Maeda, Y; Kiura, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 464OInduction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study. (24th November 2019) Authors: Saeki, S; Hotta, K; Yamaguchi, M; Harada, D; Bessho, A; Tanaka, K; Inoue, K; Gemba, K; Inoue, K; Ichihara, E; Kishimoto, J; Sasaki, T; Shioyama, Y; Katsui, K; Sasaki, J; Kiura, K; Sugio, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 511PPhase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402). (24th November 2019) Authors: Kubo, T; Nogami, N; Bessho, A; Morita, A; Ikeo, S; Yokoyama, T; Ishihara, M; Honda, T; Fujimoto, N; Murakami, S; Kaira, K; Harada, T; Nakamura, K; Iwasawa, S; Shimokawa, T; Kiura, K; Yamashita, N; Okamoto, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗